Our researchers are fighting the coronavirus pandemic with innovative approaches. With your donation you can support them in developing drugs and vaccines against the virus or in deciphering the mechanisms of disease development and progression. Here you can find out all about donation opportunities.
Learn more about how the HZI, with its translational focus, will help to facilitate a faster and more targeted approach when it comes to fighting and preventing existing, emerging or recurring infectious diseases.
Here you can find out more about the scientific results of the HZI in the research topics ”Bacterial and Viral Pathogens”, “Immune Response and Interventions” and “Anti-Infectives”.
Around 900 employees in research, administration and infrastructure, and about 220 visiting scientists from 40 different countries are employed at the Helmholtz Centre for Infection Research. To ensure top quality research we need top quality employees. Your creativity and innovative capabilities are the basis for the long-term success of our work. That's why we undertake a great deal to attract the best people to us. Learn more about this.
We communicate also through social media. Join our Facebook page, follow us on Twitter or subscribe to our YouTube-Channel.
The coronaviruses are a family of viruses that includes a series of very different pathogens. These viruses usually infect mammals, rodents, and birds, but only few coronaviruses adapted to humans. They did this with great success: About one third of all typical "common colds" and some cases of diarrhoea as well are caused by these RNA Viruses, which are the largest of their kind. We have compiled more information about the coronaviruses for you.
With the pathogen SARS-CoV-2, a novel virus that can cause respiratory diseases and pneumonia has been spreading worldwide since the end of 2019. Here we will keep you informed about current developments in research and provide answers to the most important questions.
HomeNews & EventsNews
Results 1 to 10 of total 541
HIPS scientist receives funding to develop new antibiotics
Saarbrücken researchers use bacterial communication as a target for new drugs
Researchers from Saarbrücken and Freiburg develop promising active ingredient to combat multi-resistant bacteria.
Technology developed at HIRI records ribonucleic acids in individual living cells
HZI epidemiologist honoured for SORMAS development and outstanding contributions in the field of translational infection epidemiology
Component of bacterial immune defense paralyzes infected cells and could advance molecular biology diagnostics
Change from Hamburg to Braunschweig
Pathogens are frequently usurping the host’s cytoskeleton for their own needs – new insights might lead the way towards development of novel anti-infectives
HZI research team identifies potential approach for novel therapies combating Pseudomonas aeruginosa infections
Alice McHardy, Marc Stadler and Jörg Vogel were honoured as “Highly-cited researchers”